AI-ECG Accessory Pathway Localisation Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age13-100
SponsorImperial College London
About this trial
This study seeks to validate the real-world accuracy of an AI-based algorithm for identifying the location of an accessory pathway from the 12-lead electrocardiogram
Eligibility criteria
Qualifiers
Referred for EPS procedure as part of their clinical care, with a finding of pre-excitation on their ECG
Manifest pre-excitation on their ECG any time prior to their procedure
Able to give consent
Minimum age 13 years old
Disqualifiers
Unable to give consent
Adults > 100 years old
Children < 13 years old
Patients with known location of their accessory pathway from a previous EP study
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov